Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis: possibilities for therapeutic interventions

W Wynendaele1, A T van Oosterom, A Pawinski

  • 1Laboratory of Experimental Oncology (LEO), Leuven, Belgium.

Pharmacy World & Science : PWS
|February 11, 1999
PubMed
Summary

Vascular proliferation, or angiogenesis, is crucial for development and healing but can cause diseases like diabetic retinopathy. Therapies targeting blood vessel growth are explored for cancer and wound healing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?

Clinical oncology (Royal College of Radiologists (Great Britain))·2009
Same author

Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.

Sarcoma·2007
Same author

A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same author

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

European journal of cancer (Oxford, England : 1990)·2005
Same author

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).

British journal of cancer·2005

Area of Science:

  • Biomedical Science
  • Physiology
  • Pathology

Background:

  • Vascular proliferation, or angiogenesis, is essential for embryonic development, the female reproductive cycle, and wound healing.
  • Dysregulated angiogenesis is implicated in pathological conditions, including diabetic retinopathy and myocardial infarction.
  • Understanding vascular control mechanisms is key to developing therapeutic strategies.

Purpose of the Study:

  • To summarize the control mechanisms of vascular proliferation.
  • To discuss current and potential therapeutic approaches related to angiogenesis.
  • To provide an overview of the dual role of angiogenesis in health and disease.

Main Methods:

  • Literature review of scientific articles on angiogenesis.
  • Synthesis of information on physiological and pathological angiogenesis.

Related Experiment Videos

  • Analysis of therapeutic strategies targeting blood vessel formation.

    • Main Results:

    • Angiogenesis is tightly regulated, with both insufficient and excessive formation having detrimental consequences.
    • Uncontrolled angiogenesis is a hallmark of diseases such as diabetic retinopathy.
    • Impaired blood vessel development is linked to conditions like myocardial infarction.

    Conclusions:

    • Therapeutic strategies targeting angiogenesis hold promise for various diseases.
    • Anti-angiogenic drugs are being investigated for cancer treatment.
    • Promoting angiogenesis may aid in healing conditions like non-healing ulcers.